1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
  4. > Vital Signs The Analyst%s Perspective - November 2015 Issue 

Vital Signs The Analyst%s Perspective - November 2015 Issue 

  • January 2016
  • -
  • Frost & Sullivan
  • -
  • 7 pages

This issue of Vital Signs discusses MDxHealth's launch of the SelectMDx Liquid Biopsy Test in Europe, the FDA's approval of a new treatment for non-small cell lung cancer with EGFR mutations, the clamp down on specialty pharmacies by US drug benefit managers, and BGI's strategy redirection for Complete Genomics.

Table Of Contents

Vital Signs The Analyst%s Perspective - November 2015 Issue 
MDxHealth Launches SelectMDx Liquid Biopsy Test in Europe 2
FDA Approves New Treatment for Non-small Cell Lung Cancer with EGFR Mutations 3
US Drug Benefit Managers Clamp Down on Specialty Pharmacies 4
Sequencing Service Provider Stops Planned Instrument Launch, Redirects Strategy 6

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
The Chinese Market for DNA Sequencing

The Chinese Market for DNA Sequencing

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Learn about recent advances and trends in the Chinese sequencing industry and market. - Analyze the Chinese sequencing market by workflow, including sample preparation products, ...

Next Generation Sequencing (NGS) Global market - Forecast to 2022

Next Generation Sequencing (NGS) Global market - Forecast to 2022

  • $ 4950
  • Industry report
  • November 2016
  • by IQ4I Research & Consultancy Pvt. Ltd

A decade has gone, since the first human genome has been sequenced and sequencing technology has come a long way from the time of introduction as Next generation Sequencing (NGS) has revolutionized the ...

Global Precision Medicine Market

Global Precision Medicine Market

  • $ 4250
  • Industry report
  • December 2016
  • by Mordor Intelligence LLP

The global precision medicine market is expected to reach close to USD 40 billion by the end of 2016, gradually growing at an estimated CAGR of 10.3% by 2021. Precision medicine is an emerging approach ...


Download Unlimited Documents from Trusted Public Sources

Genome Sequencing Forecast

  • January 2017
    2 pages
  • Genome Sequenci...  

View report >

Genomics Industry in the US

  • January 2017
    4 pages
  • Genomics  

  • United States  

View report >

Genomics Industry in Europe

  • January 2017
    17 pages
  • Genomics  

  • Europe  

    Denmark  

View report >

Genomics Industry

19 days ago

Genomics Industry

20 days ago

Related Market Segments :

Genome Sequencing
Genomics

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.